News and Press Releases
About the CF Foundation | Public Policy | Advocacy CF Advocates Make Their Voices Heard in 2010

This year, Cystic Fibrosis Advocates inspired new champions in Washington, D.C. and in state capitols across the country to take action on critical CF-related issues.

Dec. 10, 2010 | 2 min read
CFTR Modulators New England Journal of Medicine Publishes Study about VX-770 — A Promising Drug That Targets Underlying Defect in CF

The New England Journal of Medicine, the world's most influential and widely read medical periodical, features a study this week about a Phase 2 clinical trial of VX-770, an oral drug in development that targets the root cause of cystic fibrosis.

Nov. 17, 2010 | 3 min read
Antibiotics New Inhaled Antibiotic Cayston Gains Rapid and Broad Acceptance – 2010 NACFC

A key focus of this year's North American Cystic Fibrosis Conference (NACFC) was the progress of the more than 30 potential new therapies moving through the CF Foundation's drug development pipeline.

Nov. 15, 2010 | 2 min read
About the CF Foundation | Public Policy | Clinical Trials Michigan Teens Give U.S. Senator a Glimpse of Life with CF

This month, 15-year-old Molly Bonnell and her sister Emily, 13, who have cystic fibrosis, discovered how easy it is to make their voices heard in Congress -- without leaving their living room.

Aug. 20, 2010 | 2 min read